Patents by Inventor Koichiro Fukuoka

Koichiro Fukuoka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11795178
    Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrirnidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: October 24, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Koichiro Fukuoka, Kazuhiro Miwa, Tsuyoshi Sasaki, Fumiya Komura
  • Publication number: 20230212184
    Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
    Type: Application
    Filed: March 15, 2023
    Publication date: July 6, 2023
    Inventors: Koichiro FUKUOKA, Kazuhiro MIWA
  • Patent number: 11524957
    Abstract: The present invention provides processes and synthetic intermediates for the synthesis of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4 {3H)-one or a salt, hydrate, or tautomer thereof, or any combination thereof, which are Cdc7 kinase inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with Cdc7 activity.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: December 13, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Lei Zhu, John Daniel Bailey, Landon Durak, Joshua David Waetzig, Masahiro Mizuno, Kazuhiro Maeda, Tsuneo Yasuma, Hiroshi Yamaguchi, Koichiro Fukuoka, Kazuyuki Akiyama
  • Publication number: 20220204525
    Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrirnidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
    Type: Application
    Filed: March 14, 2022
    Publication date: June 30, 2022
    Inventors: Koichiro FUKUOKA, Kazuhiro MIWA, Tsuyoshi SASAKI, Fumiya KOMURA
  • Publication number: 20210101897
    Abstract: The present invention provides processes and synthetic intermediates for the synthesis of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4 (3H)-one or a salt, hydrate, or tautomer thereof, or any combination thereof, which are Cdc7 kinase inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with Cdc7 activity.
    Type: Application
    Filed: April 1, 2019
    Publication date: April 8, 2021
    Inventors: Lei Zhu, John Daniel Bailey, Landon Durak, Joshua David Waetzig, Masahiro Mizuno, Kazuhiro Maeda, Tsuneo Yasuma, Hiroshi Yamaguchi, Koichiro Fukuoka, Kazuyuki Akiyama
  • Patent number: 9758528
    Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethyl aminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: September 12, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Koichiro Fukuoka, Kazuhiro Miwa, Tsuyoshi Sasaki, Fumiya Komura
  • Publication number: 20170210753
    Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
    Type: Application
    Filed: April 7, 2017
    Publication date: July 27, 2017
    Inventors: Koichiro FUKUOKA, Kazuhiro MIWA, Tsuyoshi SASAKI, Fumiya KOMURA
  • Publication number: 20150266891
    Abstract: The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethyl aminomethyl-3-(6-methoxypyridazin-3-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione or salt thereof, 1,1?-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.
    Type: Application
    Filed: September 27, 2013
    Publication date: September 24, 2015
    Inventors: Koichiro Fukuoka, Kazuhiro Miwa, Tsuyoshi Sasaki, Fumiya Komura
  • Patent number: 6849738
    Abstract: The present invention provides a process for producing an intermediate for thienopyrimidine derivatives having the GnRH antagonistic activity at an industrial large scale. The process for production of the present invention relates to a process for producing a compound represented by the formula (III): wherein respective symbols have the same meanings as those described below, or a salt thereof, which comprises subjecting a compound represented by the formula (I): wherein R1 denotes hydrogen, nitro, halogen, phthalimido, mono- or di-(alkylcarbonyl)amino or alkoxy, or a salt thereof, to an acid halogenating reaction, which is successively reacted with malonic acid ester and magnesium alkoxide, treated with an acid, and reacted with sulfur and a compound represented by the formula: NCCH2COOR2 [wherein R2 denotes alkyl or aryl], or a salt thereof, in the presence of primary amine.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: February 1, 2005
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Koichiro Fukuoka, Hiroaki Yamamoto, Kazuhiro Kimura, Junichi Kawakami, Shokyo Miki
  • Publication number: 20030055269
    Abstract: The present invention provides a process for producing an intermediate for thienopyrimidine derivatives having the GnRH antagonistic activity at an industrial large scale.
    Type: Application
    Filed: August 27, 2002
    Publication date: March 20, 2003
    Inventors: Koichiro Fukuoka, Hiroaki Yamamoto, Kazuhiro Kimura, Junichi Kawakami, Shokyo Miki
  • Publication number: 20020198384
    Abstract: The present invention provides an intermediate for producing a thienopyridine derivative useful as a GnRH antagonist as well as an efficient and safe method for producing the same in an industrial scale at a high yield.
    Type: Application
    Filed: June 3, 2002
    Publication date: December 26, 2002
    Inventors: Shokyo Miki, Koichiro Fukuoka, Masahiro Akita, Junichi Kawakami, Shuichi Furuya, Yoichiro Ishimaru
  • Patent number: 6437132
    Abstract: The present invention provides an intermediate for producing a thienopyridine derivative useful as a GnRH antagonist as well as an efficient and safe method for producing the same in an industrial scale at a high yield.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: August 20, 2002
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Shokyo Miki, Koichiro Fukuoka
  • Publication number: 20020019529
    Abstract: The present invention provides an intermediate for producing a thienopyridine derivative useful as a GnRH antagonist as well as an efficient and safe method for producing the same in an industrial scale at a high yield.
    Type: Application
    Filed: July 18, 2001
    Publication date: February 14, 2002
    Inventors: Shokyo Miki, Koichiro Fukuoka, Masahiro Akita, Junichi Kawakami, Shuichi Furuya, Yoichiro Ishimaru
  • Patent number: 6313301
    Abstract: The present invention provides an intermediate for producing a thienopyridine derivative useful as a GnRH antagonist as well as an efficient and safe method for producing the same in an industrial scale at a high yield.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: November 6, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Shokyo Miki, Koichiro Fukuoka, Masahiro Akita, Junichi Kawakami, Shuichi Furuya, Yoichiro Ishimaru